Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 129,061 More Arrow 160,348 Less Arrow 38,502
Financial expenses 23,392 Less Arrow 12,468 Less Arrow 1,534
Earnings before taxes -164,592 Less Arrow -216,298 More Arrow -112,606
EBITDA -118,750 Less Arrow -202,011 More Arrow -106,099
Total assets 547,122 Less Arrow 438,945 More Arrow 461,425
Current assets 393,505 Less Arrow 310,107 More Arrow 343,154
Current liabilities 349,369 Less Arrow 219,340 Less Arrow 158,083
Equity capital 135,437 Less Arrow 115,081 More Arrow 283,924
- share capital 223,086 Less Arrow 4,489 Less Arrow 4,120
Employees (average) 71 More Arrow 89 Less Arrow 68

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 24.8% More Arrow 26.2% More Arrow 61.5%
Turnover per employee 1,818 Less Arrow 1,802 Less Arrow 566
Profit as a percentage of turnover -127.5% Less Arrow -134.9% Less Arrow -292.5%
Return on assets (ROA) -25.8% Less Arrow -46.4% More Arrow -24.1%
Current ratio 112.6% More Arrow 141.4% More Arrow 217.1%
Return on equity (ROE) -121.5% Less Arrow -188.0% More Arrow -39.7%
Change turnover -25,984 More Arrow 121,648 Less Arrow 38,502
Change turnover % -17% More Arrow 314%
Chg. No. of employees -18 More Arrow 21 Less Arrow 18
Chg. No. of employees % -20% More Arrow 31% More Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.